BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced its strategic plan to transition from a prescription to a non-prescription business model. The ...
Canvass AI’s real-time closed-loop optimization solution for process and sub-process level production allows operators and engineers to automate production processes across multiple industries and a ...
Akili (NASDAQ:AKLI) said on Wednesday that it will cut down its workforce by ~40% as it looks to transition from prescription to a non-prescription business model. The reduction in staff and resources ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback